Stocks / ACTG vs AXON

Acacia Research Corporation (ACTG) vs Axovant Sciences Ltd. Common Shares (AXON)

Acacia Research Corporation and Axovant Sciences Ltd. Common Shares side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.

AXON is the larger company ($51.0B vs $0.4B). On the fundamentals, ACTG grows revenue faster (57.1% vs 32.5%); ACTG earns a higher net margin (7.6% vs 4.5%); ACTG has the stronger return on equity (4.0% vs 3.8%). Over the last five years, AXON returned 230.3% vs -31.1%. On the filings, ACTG carries fewer potential red flags (0 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — ACTG vs AXON, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Acacia Research Corporation (ACTG)Axovant Sciences Ltd. Common Shares (AXON)
Market cap$0.4B$51.0B
Revenue (latest FY)$285.23M$2.78B
Net income (latest FY)$21.68M$124.66M
Revenue growth (5y CAGR)57.1%32.5%
Net margin7.6%4.5%
Return on equity4.0%3.8%
P/E ratio262.7
Dividend yield
Profitable years (of last 10)58
Positive free cash flowYesYes

Performance — ACTG vs AXON

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Acacia Research Corporation (ACTG)Axovant Sciences Ltd. Common Shares (AXON)
1-year return30.0%-19.6%
3-year return11.9%182.2%
5-year return-31.1%230.3%
10-year return5.8%2118.4%
52-week range$3.12–$5.27$339.01–$792.16

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full ACTG vs AXON breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open ACTG's full financials →   Open AXON's full financials →

More comparisons

Frequently asked questions

Which is bigger, ACTG or AXON?

Axovant Sciences Ltd. Common Shares is larger by market capitalization — $51.0B versus $0.4B.

Which grows faster, ACTG or AXON?

Over the last five fiscal years, Acacia Research Corporation grew revenue faster — 57.1%/yr versus 32.5%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

ACTG fundamentals → · AXON fundamentals → · All 1,500+ companies → · Free screener →